Sun Pharma Launches Drug For Mild To Moderate COVID-19 Case Treatment

On Tuesday, shares of Sun Pharma rose above 2 percent after the drugmaker announced the launch of FluGuard (Favipiravir 200 mg) at the price of Rs 35 per tablet, for the treatment of mild to moderate cases of COVID-19 in India.

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3k9Yjyd